How are Digital Transformation and Data shaping business models in the incredibly dynamic life sciences industry?
We are pleased to announce the launch of the first report of our three-part series, which explores how digital transformation is reshaping business models. Our global report explores all the issues pharma, biotech, medical devices and medtech companies need to consider.
As digital transformation reshapes business models with different emphases across regions, digitally enabled strategies are helping companies transition from product-only offerings to product-service hybrids, orient to patient mapping, pre-diagnostics solutions and enhancing treatment administration. These intertwined value chains are increasingly shaping the life sciences industry of the future.